Notice for extraordinary shareholders meeting
(Thomson Reuters ONE) - This information is subject of the disclosure requirements acc. to §5-12 vphl(Norwegian Securities Trading Act)Nutri Pharma has today sent the attached notice to shareholders of the company.The extraordinary meeting will be held on 12 February. The items on the agendarefer to corporate resolutions in connection with the potential completion ofthe offer for shares in Bionor Immuno AS (the "Offer"), including with respectto contemplated private placement of minimum NOK 50 million. In addition theagenda includes inter alia proposal for amendment of the articles of associationrelated to changes in the Norwegian company legislation which entered into forcein August 2009.[HUG#1376274] Notice for extraordinary shareholders meeting: http://hugin.info/131219/R/1376274/337831.pdf Notice for extraordinary shareholders meeting: http://hugin.info/131219/R/1376274/337832.pdf Sakkyndig redegj?se: http://hugin.info/131219/R/1376274/337833.pdf Vedlegg 1 til redegj?se: http://hugin.info/131219/R/1376274/337834.pdf
Unternehmensinformation / Kurzprofil:
Datum: 22.01.2010 - 16:55 Uhr
Sprache: Deutsch
News-ID 11357
Anzahl Zeichen: 0
contact information:
Town:
Oslo
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 181 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Notice for extraordinary shareholders meeting"
steht unter der journalistisch-redaktionellen Verantwortung von
Nutri Pharma (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
